Jubilant Biosys Limited
Amit Kumar, PhD, is an accomplished researcher with significant expertise in organic chemistry, currently serving as a Team Leader and Senior Research Scientist at Jubilant Biosys Limited since May 2019. Previously, Amit held the position of Research Scientist-Chemistry at TCG Lifesciences Pvt Ltd., where responsibilities included addressing chemistry-related challenges and supporting junior colleagues. As a Dr Kothari Postdoctoral Fellow at Jamia Hamdard, Amit focused on the design and synthesis of novel compounds as anti-inflammatory agents. Additional experience includes work as a Visiting Researcher at KU Leuven-University of Leuven, where Amit developed synthesis protocols for heterocyclic frameworks, and as a Research Associate at Jubilant Chemsys Limited, concentrating on medicinally significant heterocycles. Amit holds a PhD in Organic Chemistry from Delhi University, complemented by a Master's and Bachelor's degree in the same field.
This person is not in any teams
Jubilant Biosys Limited
1 followers
Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant’s services in discovery research include; Jubilant’s services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.